Literature DB >> 9109882

Lack of overlap in genetic risks for Alzheimer's disease and Parkinson's disease.

S F Mickel1, S K Broste, B C Hiner.   

Abstract

We explored the question of genetic overlap between Alzheimer's disease (AD) and Parkinson's disease (PD) because evidence suggests clinical, pathologic, and epidemiologic overlap between the two disorders. We compared the frequency of AD and PD between the first-degree relatives of probands with AD and PD and first-degree relatives of spouse control subjects. Using life-table methods, we found increased risk of AD in first-degree relatives of patients with AD and an increased risk of PD in first-degree relatives of patients with PD. The risk of PD in first-degree relatives of patients with AD was not increased, nor was the risk of AD in first-degree relatives of patients with PD increased. These data do not support the hypothesis that important genetic overlap exists between AD and PD.

Entities:  

Mesh:

Year:  1997        PMID: 9109882     DOI: 10.1212/wnl.48.4.942

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Spouse controls in family case-control studies: a methodological consideration.

Authors:  Bas A J Verhage; Katja K H Aben; Huub Straatman; André L M Verbeek; Terri H Beaty; Lambertus A Kiemeney
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

2.  Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study.

Authors:  Michael Y Shino; Valerie McGuire; Stephen K Van Den Eeden; Caroline M Tanner; Rita Popat; Amethyst Leimpeter; Allan L Bernstein; Lorene M Nelson
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

3.  Evidence for modest familial co-aggregation between dementia and parkinsonism.

Authors:  Adina L Feldman; Karin Wirdefeldt; Anna L V Johansson; Margaret Gatz; Nancy L Pedersen
Journal:  Eur J Epidemiol       Date:  2013-11-19       Impact factor: 8.082

4.  Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history.

Authors:  Ami R Rosen; N Kyle Steenland; John Hanfelt; Stewart A Factor; James J Lah; Allan I Levey
Journal:  Neurogenetics       Date:  2007-09-06       Impact factor: 2.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.